Prognostic and predictive biomarker developments in multiple myeloma

by Craig T. Wallington-Beddoe, Rachel L. Mynott
Published 2021-09-01

Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

by Alexander C. Lewis, Craig T. Wallington-Beddoe, Jason A. Powell, Stuart M. Pitson
Published 2021-06-01

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice

by Vicki Xie, Daochen Tong, Craig T. Wallington-Beddoe, Ken F. Bradstock, Linda J. Bendall
Published 2018-02-01

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia

by Craig T. Wallington-Beddoe, Anthony S. Don, John Hewson, Qiao Qiao, Rachael A. Papa, Richard B. Lock, Kenneth F. Bradstock, Linda J. Bendall
Published 2012-01-01

Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.

by Craig T Wallington-Beddoe, Anthony S Don, John Hewson, Qiao Qiao, Rachael A Papa, Richard B Lock, Kenneth F Bradstock, Linda J Bendall
Published 2012-01-01

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia.

by Craig T. Wallington-Beddoe, Anthony S. Don, John Hewson, Qiao Qiao, Rachael A. Papa, Richard B. Lock, Kenneth F. Bradstock, Linda J. Bendall
Published 2012-01-01